Economic/cost-effectiveness impact Archives

Home
/
Projects

Economic/cost-effectiveness impact

Cost and Cost Effectiveness of Novel Tuberculosis Vaccines in Low-and Middle-income Countries: A Systematic Review of Modelling Studies

This review addressed the costs and cost-effectiveness of novel tuberculosis (TB) vaccines compared to the current standard of care (BCG) in various settings and for different age groups in LMICs

Evolution of Tuberculosis Vaccine Modelling studies: Insights from studies in India

Ongoing

Focusing on India, we performed a scoping review to identify and evaluate studies that have used mathematical modeling to assess the epidemiological and economic impact of TB vaccine introduction in India

The implications of using different time horizons when evaluating investment to prevent infectious disease

Hypothetical vaccine

Ongoing

A lifetime time horizon is conventional for cost-effectiveness analysis, but not routine for transmission-dynamic modeling, given uncertainty in future epidemiological dynamics and high computation costs. We demonstrate implications of alternative analytic time horizons with a case study of novel tuberculosis (TB) vaccine introduction